PAPER Post A, Ackl N, Rücker M, Schreiber Y, Binder EB, Ising M, Sonntag A, Holsboer F, Almeida OF
SEARCH RESULTS
329963 RESULTS
PAPER He Y, Sun SH, Chen RW, Guo YJ, He XW, Huang L, Chen ZH, Shi K, Zhu WJ
Effects of epitopes combination and adjuvants on immune responses to anti-Alzheimer disease DNA vaccines in mice.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):171-7. PubMed: 16327342PAPER Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W
Survival among patients with dementia from a large multi-ethnic population.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):178-83. PubMed: 16327343PAPER Ampil ER, Fook-Chong S, Sodagar SN, Chen CP, Auchus AP
Ethnic variability in dementia: results from Singapore.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):184-5. PubMed: 16327344PAPER Harvey PD, Moriarty PJ, Kleinman L, Coyne K, Sadowsky CH, Chen M, Mirski DF
The validation of a caregiver assessment of dementia: the Dementia Severity Scale.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):186-94. PubMed: 16327345PAPER Lim WS, Rubin EH, Coats M, Morris JC
Early-stage Alzheimer disease represents increased suicidal risk in relation to later stages.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):214-9. PubMed: 16327348PAPER Akwa Y, Allain H, Bentue-Ferrer D, Berr C, Bordet R, Geerts H, Nieoullon A, Onteniente B, Vercelletto M
Neuroprotection and neurodegenerative diseases: from biology to clinical practice.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):226-39. PubMed: 16327350PAPER Ancoli-Israel S, Amatniek J, Ascher S, Sadik K, Ramaswamy K
Effects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot study.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):240-5. PubMed: 16327351PAPER Cellini E, Bagnoli S, Tedde A, Nacmias B, Piacentini S, Sorbi S
Insulin degrading enzyme and alpha-3 catenin polymorphisms in Italian patients with Alzheimer disease.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):246-7. PubMed: 16327352PAPER Chui HC, Gatz M
Cultural diversity in Alzheimer disease: the interface between biology, belief, and behavior.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):250-5. PubMed: 16327354PAPER Valle R
Culturally attuned recruitment, retention, and adherence in Alzheimer disease and associated disorders: a best practices working model.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):261-6. PubMed: 16327356PAPER Schneider LS
Drug development, clinical trials, cultural heterogeneity in Alzheimer disease: the need for pro-active recruitment.
Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):279-83. PubMed: 16327360Charles Glabe on SfN: Amyloid Oligomers—Not So Elusive, After All? Part 2
COMMENT Aβ oligomers have been around for as long as Aβ (Masters et al., 1985). Their significance and their relationship with fibrils has been a longstanding question that is only now becoming clearer as techniques improve. The first conformation-dependent antib
Aaron Nelson
Brigham and Women's HospitalBoston, United States
GluR1 phos Ser845
ANTIBODY polyclonal manufacturer Cat# 221-MG-1GL845 purified Glutamate Receptor & Related ImmunoKontact Human GluR1 phos Ser845 http://alzforum.org/res/com/ant/default.asp?antibodyID=12686
Current Filters
No filters selected